The Specific Aims of the Opportunity Fund Management Core (OFMC) of the Stanford CCHI are to: 1) Establish an administrative structure that will facilitate communication with the CCHI Steering Committee regarding priorities and goals for funding; 2) Establish procedures for soliciting, evaluating, prioritizing, and selecting the projects chosen for Opportunity Fund support; 3) Monitor the disbursement and tracking of Opportunity Fund awards, providing reports on the status of the Opportunity Fund at requested intervals or at least annually. 4) Ensure that all projects supported from the Opportunity Fund comply fully with all applicable Federal regulations, policies, and guidelines for research involving human subjects, including the evaluation of risks and protections in projects and appropriate ethical oversight.

Public Health Relevance

The CCHI Opportunity Fund provides a mechanism for support of resources such as technical expertise, access to specific high-cost instrumentation, bioinformatics etc. for cooperative projects involving CCHI investigators. This Opportunity Fund Management Core will follow the recommendations of the CCHI Steering Committee to set the goals, priorities and evaluation criteria for the use of the Opportunity Fund.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI057229-12
Application #
8833770
Study Section
Special Emphasis Panel (ZAI1-LAR-I)
Project Start
Project End
Budget Start
2015-04-01
Budget End
2016-03-31
Support Year
12
Fiscal Year
2015
Total Cost
$1,363,605
Indirect Cost
$518,305
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Goltsev, Yury; Samusik, Nikolay; Kennedy-Darling, Julia et al. (2018) Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging. Cell 174:968-981.e15
Gee, Marvin H; Sibener, Leah V; Birnbaum, Michael E et al. (2018) Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro. Proc Natl Acad Sci U S A 115:E7369-E7378
Cheung, Peggie; Vallania, Francesco; Warsinske, Hayley C et al. (2018) Single-Cell Chromatin Modification Profiling Reveals Increased Epigenetic Variations with Aging. Cell 173:1385-1397.e14
Mamedov, Murad R; Scholzen, Anja; Nair, Ramesh V et al. (2018) A Macrophage Colony-Stimulating-Factor-Producing ?? T Cell Subset Prevents Malarial Parasitemic Recurrence. Immunity 48:350-363.e7
Kooreman, Nigel G; Kim, Youngkyun; de Almeida, Patricia E et al. (2018) Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo. Cell Stem Cell 22:501-513.e7
Haynes, Winston A; Tomczak, Aurelie; Khatri, Purvesh (2018) Gene annotation bias impedes biomedical research. Sci Rep 8:1362
Sweeney, Timothy E; Thomas, Neal J; Howrylak, Judie A et al. (2018) Multicohort Analysis of Whole-Blood Gene Expression Data Does Not Form a Robust Diagnostic for Acute Respiratory Distress Syndrome. Crit Care Med 46:244-251
Kronstad, Lisa M; Seiler, Christof; Vergara, Rosemary et al. (2018) Differential Induction of IFN-? and Modulation of CD112 and CD54 Expression Govern the Magnitude of NK Cell IFN-? Response to Influenza A Viruses. J Immunol 201:2117-2131
Wilk, Aaron J; Blish, Catherine A (2018) Diversification of human NK cells: Lessons from deep profiling. J Leukoc Biol 103:629-641
Sweeney, Timothy E; Wynn, James L; Cernada, María et al. (2018) Validation of the Sepsis MetaScore for Diagnosis of Neonatal Sepsis. J Pediatric Infect Dis Soc 7:129-135

Showing the most recent 10 out of 249 publications